Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Sokol

Showing results (181-190 of 321) with videos related to

Pageof 33
Sort By:
Gastroenterology|June 5, 2013
Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in miceHarry Sokol, Kara L Conway, Mei Zhang, et al.
Gut|October 29, 2013
Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancerLaurent Beaugerie, Fabrice Carrat, Jean-Frédéric Colombel, et al.
Gut Microbes|September 16, 2017
Mucosa-associated microbiota dysbiosis in colitis associated cancerMathias L Richard, Giuseppina Liguori, Bruno Lamas, et al.
Journal of Crohn'S & Colitis|November 18, 2015
Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease PatientsGiuseppina Liguori, Bruno Lamas, Mathias L Richard, et al.
Frontiers in Immunology|March 13, 2020
Ozone-Induced Aryl Hydrocarbon Receptor Activation Controls Lung Inflammation via Interleukin-22 ModulationChloé Michaudel, Florent Bataille, Isabelle Maillet, et al.
Msystems|October 26, 2023
<i>Cyberlindnera jadinii</i> and <i>Kluyveromyces lactis</i>, two fungi used in food processes, have potential probiotic effects on gut inflammationCindy Hugot, Maxime Poirier, Madeleine Spatz, et al.
Microorganisms|April 28, 2023
From In Vitro to In Vivo: A Rational Flowchart for the Selection and Characterization of Candidate Probiotic Strains in Intestinal DisordersFlore Maillard, Maëva Meynier, Stanislas Mondot, et al.
Nature Communications|April 28, 2026
Faecalibacterium prausnitzii EXL01 for the Maintenance of Steroid-induced Clinical Response or Remission in Patients with Crohn's Disease: a first in human trialPerle Guarino-Vignon, Edouard Louis, Hang-Phuong Pham, et al.
Inflammatory Bowel Diseases|August 13, 2011
Anti-inflammatory properties of dairy lactobacilliClarissa Santos Rocha, Omar Lakhdari, Hervé M Blottière, et al.
Journal of Crohn'S & Colitis|June 1, 2013
Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III)Fernando Magro, Laurent Peyrin-Biroulet, Harry Sokol, et al.
Pageof 33

Showing results (181-190 of 321) with videos related to

Sort By:
Pageof 33
Gastroenterology|June 5, 2013
Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in miceHarry Sokol, Kara L Conway, Mei Zhang, et al.
Gut|October 29, 2013
Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancerLaurent Beaugerie, Fabrice Carrat, Jean-Frédéric Colombel, et al.
Gut Microbes|September 16, 2017
Mucosa-associated microbiota dysbiosis in colitis associated cancerMathias L Richard, Giuseppina Liguori, Bruno Lamas, et al.
Journal of Crohn'S & Colitis|November 18, 2015
Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease PatientsGiuseppina Liguori, Bruno Lamas, Mathias L Richard, et al.
Frontiers in Immunology|March 13, 2020
Ozone-Induced Aryl Hydrocarbon Receptor Activation Controls Lung Inflammation via Interleukin-22 ModulationChloé Michaudel, Florent Bataille, Isabelle Maillet, et al.
Msystems|October 26, 2023
<i>Cyberlindnera jadinii</i> and <i>Kluyveromyces lactis</i>, two fungi used in food processes, have potential probiotic effects on gut inflammationCindy Hugot, Maxime Poirier, Madeleine Spatz, et al.
Microorganisms|April 28, 2023
From In Vitro to In Vivo: A Rational Flowchart for the Selection and Characterization of Candidate Probiotic Strains in Intestinal DisordersFlore Maillard, Maëva Meynier, Stanislas Mondot, et al.
Nature Communications|April 28, 2026
Faecalibacterium prausnitzii EXL01 for the Maintenance of Steroid-induced Clinical Response or Remission in Patients with Crohn's Disease: a first in human trialPerle Guarino-Vignon, Edouard Louis, Hang-Phuong Pham, et al.
Inflammatory Bowel Diseases|August 13, 2011
Anti-inflammatory properties of dairy lactobacilliClarissa Santos Rocha, Omar Lakhdari, Hervé M Blottière, et al.
Journal of Crohn'S & Colitis|June 1, 2013
Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III)Fernando Magro, Laurent Peyrin-Biroulet, Harry Sokol, et al.
Pageof 33